The FY2024 (Dec) proxy of Castle Biosciences names 17 peer companies for pay. Among Castle Biosciences and these peers, CEO pay was 7th highest of 9 and total shareholder return was 5th highest of 9.
7th highest of 9in Castle Biosciences and its pay peers, FY2024 (Dec) by CEO pay:
$5.0M$13.0M
5th highest of 9in Castle Biosciences and its pay peers, FY2024 (Dec) by total shareholder return:
$20$470
Pay peer group, FY2024 (Dec) proxy
| Natera | ||
| Neogenomics | ||
| CareDx | ||
| Pacific Biosciences Of California | ||
| Adma Biologics | ||
| Twist Bioscience | ||
| Veracyte | ||
| Adaptive Biotechnologies | ||
| Axonics, Inc. | Not disclosed | Not disclosed |
| Biocryst Pharmaceuticals | Not disclosed | Not disclosed |
| Guardant Health | Not disclosed | Not disclosed |
| Invitae Corporation | Not disclosed | Not disclosed |
| Mesa Laboratories Inc /Co/ | Not disclosed | Not disclosed |
| OraSure Technologies, Inc. | Not disclosed | Not disclosed |
| Quanterix Corporation | Not disclosed | Not disclosed |
| Silk Road Medical, Inc. | Not disclosed | Not disclosed |
| iRhythm Technologies, Inc. | Not disclosed | Not disclosed |
17 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.